---
title: "On September 24th, LIVZON PHARMA spent CNY 4.9977 million to repurchase 128,300 A shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/258670718.md"
description: "According to the Zhitong Finance APP, LIVZON PHARMA announced that it spent CNY 4.9977 million to repurchase 128,300 A-shares on September 24, 2025"
datetime: "2025-09-24T10:01:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258670718.md)
  - [en](https://longbridge.com/en/news/258670718.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258670718.md)
generator: "portal-rs"
---

# On September 24th, LIVZON PHARMA spent CNY 4.9977 million to repurchase 128,300 A shares

According to the Zhitong Finance APP, LIVZON PHARMA (01513) announced that it spent CNY 4.9977 million to repurchase 128,300 A-shares on September 24, 2025

### Related Stocks

- [000513.CN](https://longbridge.com/en/quote/000513.CN.md)
- [01513.HK](https://longbridge.com/en/quote/01513.HK.md)

## Related News & Research

- [Livzon MABPharm wins China approval for Lecankitug psoriasis injection](https://longbridge.com/en/news/297167246.md)
- [FOSUN INTL Files HK Listing Application for Spin-off of Resort Biz Club Med](https://longbridge.com/en/news/297453168.md)
- [Ocumension says China regulator accepts domestic filing for dexamethasone eye injection OT-502](https://longbridge.com/en/news/297648398.md)
- [7,448 Shares in ITT Inc. $ITT Purchased by Fosun International Ltd](https://longbridge.com/en/news/297484108.md)
- [Fosun cuts Shangmeng Technology capital increase to RMB 41.11 million for 20% stake](https://longbridge.com/en/news/297632639.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**